Follow
Branko Braam
Branko Braam
Unknown affiliation
Verified email at ualberta.ca
Title
Cited by
Cited by
Year
Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes
CJM Loomans, EJP de Koning, FJT Staal, MB Rookmaaker, C Verseyden, ...
Diabetes 53 (1), 195-199, 2004
11582004
Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial
L Bax, AJJ Woittiez, HJ Kouwenberg, WPTM Mali, E Buskens, FJA Beek, ...
Annals of internal medicine 150 (12), 840-848, 2009
8732009
The severe cardiorenal syndrome:‘Guyton revisited’
LG Bongartz, MJ Cramer, PA Doevendans, JA Joles, B Braam
European heart journal 26 (1), 11-17, 2005
7612005
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients
CE van Iperen, CAJM Gaillard, RJ Kraaijenhagen, BG Braam, JJM Marx, ...
Critical care medicine 29 (9), S193-S198, 2001
3132001
Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure
K Van der Putten, B Braam, KE Jie, CAJM Gaillard
Nature clinical practice Nephrology 4 (1), 47-57, 2008
2772008
Assessment of renal autoregulation
WA Cupples, B Braam
American Journal of Physiology-Renal Physiology 292 (4), F1105-F1123, 2007
2312007
Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats.
LG Navar, L Lewis, A Hymel, B Braam, KD Mitchell
Journal of the American Society of Nephrology 5 (4), 1153-1158, 1994
2221994
Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology
TJ Rabelink, KAH Kaasjager, P Boer, EG Stroes, B Braam, HA Koomans
Kidney international 46 (2), 376-381, 1994
2121994
Empagliflozin blunts worsening cardiac dysfunction associated with reduced NLRP3 (nucleotide-binding domain-like receptor protein 3) inflammasome activation in heart failure
NJ Byrne, N Matsumura, ZH Maayah, M Ferdaoussi, S Takahara, ...
Circulation: Heart Failure 13 (1), e006277, 2020
1982020
Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI)
PA McCullough, JA Kellum, M Haase, C Müller, K Damman, PT Murray, ...
ADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes 182, 82-98, 2013
1932013
Cardiorenal syndrome—current understanding and future perspectives
B Braam, JA Joles, AH Danishwar, CA Gaillard
Nature Reviews Nephrology 10 (1), 48-55, 2014
1812014
Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system
MA Osman, M Alrukhaimi, GE Ashuntantang, E Bellorin-Font, MB Gharbi, ...
Kidney international supplements 8 (2), 52-63, 2018
1672018
Tetrahydrobiopterin, but Not l-Arginine, Decreases NO Synthase Uncoupling in Cells Expressing High Levels of Endothelial NO Synthase
LM Bevers, B Braam, JA Post, AJ van Zonneveld, TJ Rabelink, ...
Hypertension 47 (1), 87-94, 2006
1612006
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors
KE Jie, MC Verhaar, MJM Cramer, K Van Der Putten, CAJM Gaillard, ...
American Journal of Physiology-Renal Physiology 291 (5), F932-F944, 2006
1392006
Perinatal l-Arginine and Antioxidant Supplements Reduce Adult Blood Pressure in Spontaneously Hypertensive Rats
S Racasan, B Braam, DM van der Giezen, R Goldschmeding, P Boer, ...
Hypertension 44 (1), 83-88, 2004
1332004
Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure
B Braam, WA Cupples, JA Joles, C Gaillard
Heart failure reviews 17, 161-175, 2012
1262012
The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the …
L Bax, WP Mali, E Buskens, HA Koomans, JJ Beutler, B Braam, FJ Beek, ...
Journal of nephrology 16 (6), 807-812, 2003
1262003
Everything we always wanted to know about furosemide but were afraid to ask
X Huang, E Dorhout Mees, P Vos, S Hamza, B Braam
American Journal of Physiology-Renal Physiology 310 (10), F958-F971, 2016
1152016
Hepcidin‐25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients
K van der Putten, KE Jie, D van den Broek, RJ Kraaijenhagen, ...
European journal of heart failure 12 (9), 943-950, 2010
1142010
Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations
SM Bagshaw, EA Hoste, B Braam, C Briguori, JA Kellum, PA McCullough, ...
ADQI Consensus on AKI Biomarkers and Cardiorenal Syndromes 182, 137-157, 2013
1132013
The system can't perform the operation now. Try again later.
Articles 1–20